ArticleJournal of pharmaceutical policy and practice2021
Drug supply shortage in Nigeria during COVID-19: efforts and challenges.
Article in Journal of pharmaceutical policy and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Trial
- Impact of drug shortages on the work of hospital pharmacists in Japan.Journal of pharmaceutical policy and practice · 2026Article
- Factors contributing to human and veterinary medicine shortages in developing countries: perspectives of suppliers and regulators in Namibia.Tropical medicine and health · 2025Article
- Disruptions in Tiopronin therapy: impacts on clinical outcomes of pediatric cystinuria patients during the COVID-19 pandemic.Urolithiasis · 2025Article
- Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems.Tropical diseases, travel medicine and vaccines · 2025Review
- Nigeria's Pharmaceutical Industry: Addressing Over-Reliance on Importation and Proposing Sustainable Solutions.Innovations in pharmacy · 2025Article
- Perceptions, attitudes and experiences of hospital pharmacists working in the private sector regarding drug shortage in Lebanon: a national cross-sectional study.Journal of pharmaceutical policy and practice · 2025Article
- Addressing Drug Shortages at Mediclinic Parkview Hospital: A Five-Year Study of Challenges, Impact, and Strategies.Cureus · 2024Article
- Article
- Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach.Scientific reports · 2023Article
- Assessment of Availability of Tracer Drugs and Basic Diagnostics at Public Primary Health Care Facilities in Ethiopia During COVID-19 Pandemic.Ethiopian journal of health sciences · 2023Article
- Health Care Implications of the COVID-19 Pandemic for the Cardiovascular Practitioner.The Canadian journal of cardiology · 2023Review
- Oral contraceptive pills shortage in Lebanon amidst the economic collapse: a nationwide exploratory study.BMC health services research · 2023Article
- Identifying resilience strategies for disruption management in the healthcare supply chain during COVID-19 by digital innovations: A systematic literature review.Informatics in medicine unlocked · 2023Review
- Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond.Journal of the American College of Clinical Pharmacy : JACCP · 2022Article
- Drug shortages in low- and middle-income countries: Colombia as a case study.Journal of pharmaceutical policy and practice · 2022Article
- Revisiting the issue of access to medicines in Africa: Challenges and recommendations.Public health challenges · 2022Review
- Prevention and control of COVID-19 by primary health care facilities in China: a field-survey-based qualitative study in three typical cities.BMC health services research · 2022Article
- COVID-19 disruption to medicine supply in Bangladesh: Searching for a solution to drug shortages.Public health in practice (Oxford, England) · 2021Article
- Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling.Innovations in pharmacy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of the drug supply is imported creating a huge supply-demand disparity particularly in times like COVID-19. Nigeria is in need of huge quantities of quality-assured health commodities to effectively respond to the pandemic. Significant shortages of other essential medicines and medical products across the country could be imminent. Drug scarcity in Nigeria during the COVID-19 pandemic period is because of several accumulated factors, majorly as a result of global lockdown, decreased manufacturing, unaddressed regulatory affairs, poor access to resources by the population, lack of buffer stocks, security instability, and poor funding of the healthcare system. This situation if left unattended, could cause serious drawbacks to the health of the populace as well as the quality of life of Nigerians amid the COVID-19 Pandemic. Appropriate measures should be directed to ensure ethical processes on drug production, importation, pricing, and distribution to avoid such events during unavoidable scenarios, like the COVID-19 pandemic and other public health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.